Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?
Journal: Allergy and asthma proceedings
Published: September 17, 2025
Activated PI3K Delta Syndrome: A Case Presentation and Literature Review.
Journal: Cureus
Published: August 11, 2025
A rare case report of activated PI3K delta syndrome (APDS): diagnostic pitfalls.
Journal: BMC pediatrics
Published: July 31, 2025
Recurrent Macular Vasculitis in Hypergammaglobulinemia as an Underrecognized Presenting Manifestation of Activated PI3K Delta Syndrome.
Journal: Pediatric dermatology
Published: July 13, 2025
Spanish Consensus on the Diagnosis and Management of Patients With Activated PI3K Delta Syndrome (APDS).
Journal: Journal of investigational allergology & clinical immunology
Published: March 03, 2025
Recurrent Panuveitis as a Manifestation of a Novel PIK3CD Gene Mutation: A Diagnostic and Management Challenge.
Journal: Ocular immunology and inflammation
Published: February 11, 2025
Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment.
Journal: Cell
Published: January 24, 2025
Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome.
Journal: The Journal of pediatrics
Published: December 12, 2024
Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1).
Journal: The journal of allergy and clinical immunology. Global
Published: November 29, 2024
Disseminated Ureaplasma urealyticum Infection and Hyperammonemic Encephalopathy in a Patient With Activated PI3K Delta Syndrome 2.
Journal: Open forum infectious diseases
Published: November 01, 2024
Expert insights on Hodgkin's lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment.
Journal: Frontiers in immunology
Published: October 26, 2024
PI3K GOF leads to dysregulation of T and B cells that both contribute to extrinsically driving activation and differentiation of other CD4+ T cells.
Journal: Immunology and cell biology
Published: October 12, 2024
Last Updated: 01/07/2026